TF-PROTACは,トランスクリプション・ファクターの標的化された劣化を可能にします
Jing Liu1, He Chen2, H Ümit Kaniskan2
1Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, United States.
Journal of the American Chemical Society
|June 8, 2021
まとめ
トランスクリプション・ファクター (TF) は薬効性のない標的ですが,TF-PROTACは新しい戦略を提供します. これらの分子はDNAを使って 選択的にTFを分解し 癌治療の有望性を示しています
科学分野:
- 分子生物学
- 薬物の発見
- 生物化学
背景:
- 転写因子 (TFs) は癌のような人間の病気において重要な役割を果たしますが,大抵は薬剤で治療できません.
- 現在の治療戦略はTFのほとんどを 効果的にターゲットにするのに苦労しています
- タンパク質分解標的キメラ (PROTACs) は,ユビキチン- プロテアゾーム系を通じて標的タンパク質を分解する.
研究 の 目的:
- 転写因子の選択的分解のための新しいプラットフォーム,TF-PROTACsを開発する.
- TF-PROTACsが特定のTFを分解する効果と,その治療的可能性を実証する.
主な方法:
- クリック化学によるDNAオリゴヌクレオチドとE3リガゼリガンドを結びつけるTF-PROTACプラットフォームの開発.
- NF-κB (p65) とE2F1をターゲットとするVHLベースのTF-PROTACの設計と合成
- 細胞モデルにおけるTF分解と抗増殖効果の検証
主要な成果:
- TF- PROTACsは細胞内の内生性p65およびE2F1タンパク質を成功して選択的に分解した.
- 開発されたTF- PROTACs (dNF- kBとdE2F) は強力な抗増殖効果を示した.
- DNAのオリゴヌクレオチド成分がTF分解の特異性を決定する.
結論:
- TF-PROTACは,ターゲット化されたTFの劣化のための汎用性のあるプラットフォームを表しています.
- このアプローチは,これまで薬剤で治療できなかった転写因子を標的とした普遍的な戦略を提供します.
- TF-PROTACsは,新しいがん治療法の開発に重要な可能性を秘めています.
関連する概念動画
General Transcription Factors
6.1K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
6.1K
Transcription Factors
79.8K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
79.8K
Transcription Attenuation in Prokaryotes
16.6K
Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure. Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
16.6K
TGF - β Signaling Pathway
8.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
8.2K
Master Transcription Regulators
7.3K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.3K
Master Transcription Regulators
2.4K
2.4K


